Imap is specifically used to treat schizophrenia and severe, chronic thought disorders. It works by modifying the activity of brain chemicals, such as dopamine, which play a key role in the development of psychotic symptoms. It can also contribute to improving psychological stability and reducing relapses in patients with long-term mental disorders. In addition,
Imap may sometimes be prescribed for some cases related to severe anxiety or severe mood swings. However, it is not the first-line treatment recommended for these conditions due to the need for close monitoring and potential side effects.